Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200410354> ?p ?o ?g. }
- W4200410354 endingPage "13462" @default.
- W4200410354 startingPage "13462" @default.
- W4200410354 abstract "The World Health Organization reported that approximately 324,000 new cases of melanoma skin cancer were diagnosed worldwide in 2020. The incidence of melanoma has been increasing over the past decades. Targeting apoptotic pathways is a potential therapeutic strategy in the transition to preclinical models and clinical trials. Some naturally occurring products and synthetic derivatives are apoptosis inducers and may represent a realistic option in the fight against the disease. Thus, chalcones have received considerable attention due to their potential cytotoxicity against cancer cells. We have previously reported a chalcone containing an indole and a pyridine heterocyclic rings and an α-bromoacryloylamido radical which displays potent antiproliferative activity against several tumor cell lines. In this study, we report that this chalcone is a potent apoptotic inducer for human melanoma cell lines SK-MEL-1 and MEL-HO. Cell death was associated with mitochondrial cytochrome c release and poly(ADP-ribose) polymerase cleavage and was prevented by a non-specific caspase inhibitor. Using SK-MEL-1 as a model, we found that the mechanism of cell death involves (i) the generation of reactive oxygen species, (ii) activation of the extrinsic and intrinsic apoptotic and mitogen-activated protein kinase pathways, (iii) upregulation of TRAIL, DR4 and DR5, (iv) downregulation of p21Cip1/WAF1 and, inhibition of the NF-κB pathway." @default.
- W4200410354 created "2021-12-31" @default.
- W4200410354 creator A5001432282 @default.
- W4200410354 creator A5015909622 @default.
- W4200410354 creator A5032954885 @default.
- W4200410354 creator A5041567500 @default.
- W4200410354 creator A5050575004 @default.
- W4200410354 creator A5053376200 @default.
- W4200410354 creator A5068897861 @default.
- W4200410354 creator A5070001983 @default.
- W4200410354 creator A5090825685 @default.
- W4200410354 date "2021-12-15" @default.
- W4200410354 modified "2023-09-26" @default.
- W4200410354 title "Apoptosis Pathways Triggered by a Potent Antiproliferative Hybrid Chalcone on Human Melanoma Cells" @default.
- W4200410354 cites W1509669696 @default.
- W4200410354 cites W1891236388 @default.
- W4200410354 cites W1968366612 @default.
- W4200410354 cites W1976294091 @default.
- W4200410354 cites W1984132569 @default.
- W4200410354 cites W2008627790 @default.
- W4200410354 cites W2012191027 @default.
- W4200410354 cites W2019418709 @default.
- W4200410354 cites W2021536610 @default.
- W4200410354 cites W2028752124 @default.
- W4200410354 cites W2035331118 @default.
- W4200410354 cites W2048620835 @default.
- W4200410354 cites W2049171090 @default.
- W4200410354 cites W2051201608 @default.
- W4200410354 cites W2052793452 @default.
- W4200410354 cites W2053080813 @default.
- W4200410354 cites W2053962169 @default.
- W4200410354 cites W2066990547 @default.
- W4200410354 cites W2068004114 @default.
- W4200410354 cites W2074688366 @default.
- W4200410354 cites W2081216494 @default.
- W4200410354 cites W2092524729 @default.
- W4200410354 cites W2106006192 @default.
- W4200410354 cites W2106285227 @default.
- W4200410354 cites W2108958930 @default.
- W4200410354 cites W2117692326 @default.
- W4200410354 cites W2121745326 @default.
- W4200410354 cites W2129778797 @default.
- W4200410354 cites W2142325519 @default.
- W4200410354 cites W2146983373 @default.
- W4200410354 cites W2151325092 @default.
- W4200410354 cites W2171808166 @default.
- W4200410354 cites W2220812108 @default.
- W4200410354 cites W2294327427 @default.
- W4200410354 cites W2317505839 @default.
- W4200410354 cites W2318380017 @default.
- W4200410354 cites W2338127681 @default.
- W4200410354 cites W2520632143 @default.
- W4200410354 cites W2618573553 @default.
- W4200410354 cites W2621333085 @default.
- W4200410354 cites W2766197806 @default.
- W4200410354 cites W2788640168 @default.
- W4200410354 cites W2795000938 @default.
- W4200410354 cites W2795996504 @default.
- W4200410354 cites W2806967085 @default.
- W4200410354 cites W2885608817 @default.
- W4200410354 cites W2898386270 @default.
- W4200410354 cites W2899645070 @default.
- W4200410354 cites W2904157729 @default.
- W4200410354 cites W2915045061 @default.
- W4200410354 cites W2940731404 @default.
- W4200410354 cites W2976481372 @default.
- W4200410354 cites W3011426090 @default.
- W4200410354 cites W3016877592 @default.
- W4200410354 cites W3043169519 @default.
- W4200410354 cites W3083602444 @default.
- W4200410354 cites W3086473620 @default.
- W4200410354 cites W3108128773 @default.
- W4200410354 cites W3119005666 @default.
- W4200410354 cites W3128646645 @default.
- W4200410354 cites W3191405113 @default.
- W4200410354 doi "https://doi.org/10.3390/ijms222413462" @default.
- W4200410354 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34948260" @default.
- W4200410354 hasPublicationYear "2021" @default.
- W4200410354 type Work @default.
- W4200410354 citedByCount "5" @default.
- W4200410354 countsByYear W42004103542022 @default.
- W4200410354 countsByYear W42004103542023 @default.
- W4200410354 crossrefType "journal-article" @default.
- W4200410354 hasAuthorship W4200410354A5001432282 @default.
- W4200410354 hasAuthorship W4200410354A5015909622 @default.
- W4200410354 hasAuthorship W4200410354A5032954885 @default.
- W4200410354 hasAuthorship W4200410354A5041567500 @default.
- W4200410354 hasAuthorship W4200410354A5050575004 @default.
- W4200410354 hasAuthorship W4200410354A5053376200 @default.
- W4200410354 hasAuthorship W4200410354A5068897861 @default.
- W4200410354 hasAuthorship W4200410354A5070001983 @default.
- W4200410354 hasAuthorship W4200410354A5090825685 @default.
- W4200410354 hasBestOaLocation W42004103541 @default.
- W4200410354 hasConcept C104317684 @default.
- W4200410354 hasConcept C121608353 @default.
- W4200410354 hasConcept C127561419 @default.
- W4200410354 hasConcept C182979987 @default.
- W4200410354 hasConcept C185592680 @default.